Beijing Xingyu Zhongke Investment

Beijing Xingyu Zhongke Investment is a specialized investment and technology group based in Beijing, China, focusing on the healthcare and life sciences sectors. The firm operates a venture capital arm that provides strategic funding to innovative biotechnology and medical device startups. Additionally, through its subsidiary Beijing Xingyu Zhongke Technology, the company develops and commercializes advanced platforms for exosome isolation and purification. Their proprietary EXO-P series of products is widely used in research settings for the study of extracellular vesicles and their roles in diagnostics and therapeutics. The company is a key player in the Chinese exosome research community, often facilitating academic and industrial collaborations. Its investment portfolio includes significant stakes in various biopharmaceutical companies, emphasizing its commitment to advancing medical innovation.